Cape Verde vs Israel: HIV-positive TB patients on ART (antiretroviral therapy)
Cape Verde
100.0%
in 2024
Israel
100.0%
in 2024
Cape Verde rank
1st
Israel rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Cape Verde
- Israel
How they compare
Cape Verde currently reports 100.0% against 100.0% in Israel, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Israel ahead.
Cape Verde ranks 1st and Israel ranks 1st of 144 countries.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cape Verde | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 91.2% | 100.0% | 8.8% | Israel |
| 2020s | 90.4% | 98.2% | 7.8% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Cape Verde or Israel?
- Cape Verde, at 100.0% against 100.0% in Israel as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Cape Verde and Israel?
- 0.0%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Israel?
- 10 years are reported by both, from 2015 to 2024.
- How do Cape Verde and Israel rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Cape Verde ranks 1st and Israel ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.